author-photo

Alexander Lee

University of California, Los Angeles

18

Papers

458

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

IMMU-41. NEOADJUVANT PD-1 BLOCKADE INDUCES T CELL AND CDC1 ACTIVATION BUT FAILS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR ASSOCIATED MACROPHAGES IN RECURRENT GLIOBLASTOMA

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
CTIM-18. DENDRITIC CELL VACCINATION IN CONJUNCTION WITH ADJUVANT TLR-3 AGONIST ADMINISTRATION ENHANCES PRO-INFLAMMATORY IMMUNE RESPONSES AND IS ASSOCIATED WITH EXTENDED SURVIVAL IN MALIGNANT GLIOMA PATIENTS

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (25)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

2019 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (425)
IRIS: Big data-informed discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (3)
IMMU-02. NEOANTIGENS ARISING FROM ALTERNATIVE SPLICING EVENTS MAY BE TARGETED BY TUMOR INFILTRATING LYMPHOCYTES IN GLIOBLASTOMAS

2019 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (3)
ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (1)
ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (1)
IMMU-20. CHARACTERIZING THE IMMUNE LANDSCAPE OF PD-1/PD-L1 IN BRAIN TUMOR IMMUNE CELL POPULATION USING CyTOF MASS CyTOMETRY

2017 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)